Exploring the efficacy and contribution of Dupilumab in asthma management
Author:
Publisher
Elsevier BV
Subject
Molecular Biology,Immunology
Reference95 articles.
1. Nitric oxide pathway as a potential therapeutic target in COVID-19;Alkharfy;Farmacia,2020
2. Regulation of Th2 differentiation and Il4 locus accessibility;Ansel;Annu. Rev. Immunol.,2006
3. A critical evaluation of anti-IL-13 and anti-IL-4 strategies in severe asthma;Bagnasco;Int. Arch. Allergy Immunol.,2016
4. The differential expression of IL-4 and IL-13 and its impact on type-2 immunity;Bao;Cytokine,2015
5. Dupilumab in the management of moderate-to-severe asthma: the data so far;Barranco;Ther. Clin. risk Manag.,2017
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prediction of Clinical Response to Dupilumab in Patients with Severe Asthma Using Fractional Exhaled Nitric Oxide Combined with Pulmonary Function Testing;International Archives of Allergy and Immunology;2024
2. Hyperthyroidism in a 15-year-old adolescent treated with Dupilumab for severe allergic asthma and atopic dermatitis;Allergologia et Immunopathologia;2023-05-01
3. Effects of IL-4, IL-5, and IL-13 on total and allergy specific IgE production in patients with allergic rhinitis;2ND INTERNATIONAL CONFERENCE ON APPLIED RESEARCH AND ENGINEERING (ICARAE2022);2023
4. A Pilot Study of Associations Between the Occurrence of Palpitations and Cytokine Gene Variations in Women Prior to Breast Cancer Surgery;Biological Research For Nursing;2022-10-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3